Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified 2′ and 3′ nucleoside prodrugs for treating flaviviridae infections

Modified 2′ and 3′ nucleoside prodrugs for treating flaviviridae infections

US Patent 8637475 · Granted Jan 28, 2014

Estimated economic value: $19,583,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Advantageous anti-HCV combination therapy2025
Highly active compounds against COVID-192025
Crystalline epinephrine malonate salt2024
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nuc2024
Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus2024
2′-substituted-N6-substituted purine nucleotides for RNA virus treatment2024
Highly active compounds against COVID-192023
Highly active compounds against COVID-192023
Highly active compounds against COVID-192023
Treatment of HCV infected patients with cirrhosis2023
Crystalline epinephrine malonate salt2022
Crystalline epinephrine malonate salt2021